Confidence in Your Nitrosamine Impurity Analysis

After the discovery of unacceptable levels of nitrosamine contaminations in certain drug products, regulatory agencies around the world have mandated stringent guidelines and analytical testing of all pharmaceuticals, especially chemically synthesized ones, to control and limit the level of these genotoxic impurities in drugs. To ensure patient health and safety, pharmaceutical manufacturers must develop highly selective and sensitive methods to meet these requirements.